ASP6858

· Astellas Pharma Europe B.V.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ASP6858, covering 2016-06-21 to 2016-06-21. Get the full timeline:

Most recent: Clinical Trial Update: A Combined Single and Multiple Ascending Dose Study of ASP6858 in Healthy Subjects [Phase 1]